Evidence map›Paper›PMID 35625304›Full record

ReviewAntibiotics (Basel, Switzerland)2022

Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States.

Kenneth P Klinker, Levita K Hidayat, Eric Wenzler, Joan-Miquel Balada-Llasat, Mary Motyl, C Andrew DeRyke, Karri A Bauer

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kenneth P KlinkerMerck & Co., Inc., 2000 Galloping Hill Rd., Kenilworth, NJ 07033, USA.
Levita K HidayatMerck & Co., Inc., 2000 Galloping Hill Rd., Kenilworth, NJ 07033, USA.
Eric WenzlerDepartment of Pharmacy Practice, College of Pharmacy, University of Illinois Chicago, 833 South Wood St., Room 164, Chicago, IL 60612, USA.ORCID 0000-0003-3914-8400
Joan-Miquel Balada-LlasatDepartment of Clinical Microbiology and Clinical Pathology, The Ohio State University Wexner Medical Center, 181 Taylor Ave., Columbus, OH 43203, USA.
Mary MotylMerck & Co., Inc., 2000 Galloping Hill Rd., Kenilworth, NJ 07033, USA.
C Andrew DeRykeMerck & Co., Inc., 2000 Galloping Hill Rd., Kenilworth, NJ 07033, USA.
Karri A BauerMerck & Co., Inc., 2000 Galloping Hill Rd., Kenilworth, NJ 07033, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance is a global public health threat, and gram-negative bacteria, such as Enterobacterales and

Indexed as

cefepimeceftolozane/tazobactamEnterobacteralesextended-spectrum β-lactamaseimipenem/relebactammeropenempiperacillin/tazobactamPseudomonas aeruginosasusceptibility testingsyndromic antibiogram

Identifiers

PMID35625304
PMCPMC9137455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.